ScholarIQanswers from OpenAlex & ORCID
Daniel Ontaneda
ResearcherPublications, citations & collaboration network
Daniel Ontaneda is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel Ontaneda have?
ScholarIQindexed works
Daniel Ontaneda has 309 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel Ontaneda have?
ScholarIQcitation count
Daniel Ontaneda has 6,321 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel Ontaneda?
ScholarIQh-index
Daniel Ontaneda has an h-index of 42 in OpenAlex.
What is the i10-index of Daniel Ontaneda?
ScholarIQi10-index
Daniel Ontaneda has an i10-index of 102 in OpenAlex.
What is the ORCID of Daniel Ontaneda?
ScholarIQorcid
The ORCID for Daniel Ontaneda is on the source record.
What is the OpenAlex record for Daniel Ontaneda?
ScholarIQopenalex
The OpenAlex for Daniel Ontaneda is on the source record.
What are the most-cited papers on Daniel Ontaneda?
ScholarIQmost cited works
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
on behalf of the NAIMS Cooperative, Pascal Sati, Jiwon Oh, R. Todd Constable, Nikos Evangelou, Charles R.G. Guttmann, Roland G. Henry, Eric C. Klawiter, Caterina Mainero, Luca Massacesi, Henry F. McFarland, Flavia Nelson, Daniel Ontaneda, Alexander Rauscher, William D. Rooney, Amal Samaraweera, Russell T. Shinohara, Raymond A. Sobel, Andrew Solomon, Constantina A. Treaba, Jens Wuerfel, Robert Zivadinov, Nancy L. Sicotte, Daniel Pelletier, Daniel S. Reich
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Xavier Montalbán, Christine Lebrun‐Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Maria Pia Amato, Lilyana Amezcua, Brenda Banwell, Amit Bar-Or, Frederik Barkhof, Helmut Butzkueven, Olga Ciccarelli, Jeremy Chataway, Jeffrey A. Cohen, Giancarlo Comi, Jorge Correale, Florian Deisenhammer, Massimo Filippi, Julie Fiol, Mark S. Freedman, Kazuo Fujihara, Cristina Granziera, Ari Green, Hans-Peter Hartung, Kerstin Hellwig, L Kappos, Dorlan Kimbrough, Joep Killestein, Fred Lublin, Romain Marignier, Ruth Ann Marrie, Aaron Miller, Susana Otero-Romero, Daniel Ontaneda, Sudarshini Ramanathan, Daniel Reich, Maria A. Rocca, Àlex Rovira, Shiv Saidha, Amber Salter, Jaume Sastre‐Garriga, Deanna Saylor, Andrew Solomon, Maria Pia Sormani, Bruno Stankoff, Mar Tintoré, Helen Tremlett, Anneke van der Walt, Shanthi Viswanathan, Heinz Wiendl, Brigitte Wildemann, Bassem Yamout, Paola Zaratin, Peter A. Calabresi, Timothy Coetzee, Alan J. Thompson
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
Daniel Ontaneda, Alan J. Thompson, Robert J. Fox, Jeffrey A. Cohen
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
Robert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason, Andrew Goodman, Eric C. Klawiter, Kazuko Matsuda, Michelle McGovern, Robert T. Naismith, Akshata Ashokkumar, Janel Barnes, Dixie Ecklund, Elizabeth Klingner, Maxine Koepp, Jeffrey D. Long, Sneha Natarajan, Brenda Thornell, Jon Yankey, Robert Bermel, Josef P. Debbins, Xuemei Huang, Patricia Jagodnik, Mark J. Lowe, Kunio Nakamura, Sridar Narayanan, Ken E. Sakaie, Bhaskar Thoomukuntla, Xiaopeng Zhou, Stephen Krieger, Enrique Álvarez, Michelle Apperson, Khurram Bashir, Bruce A. Cohen, Patricia K. Coyle, Silvia Delgado, L. Dana DeWitt, Angela Flores, Barbara S. Giesser, Myla Goldman, Burk Jubelt, Neil Lava, Sharon Lynch, Harold L. Moses, Daniel Ontaneda, Jai Perumal, Michael K. Racke, Pavle Repovic, Claire Riley, Christopher Severson, Shlomo Shinnar, Valerie Suski, Bianca Weinstock-Guttman, Vijayshree Yadav, Aram Zabeti
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
Daniel Ontaneda, Robert J. Fox, Jeremy Chataway